Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Helping alveolar macrophages live to fight another day during viral pneumonia
Elise M.R. Armstrong, Joseph P. Mizgerd
Elise M.R. Armstrong, Joseph P. Mizgerd
View: Text | PDF
Commentary

Helping alveolar macrophages live to fight another day during viral pneumonia

  • Text
  • PDF
Abstract

Alveolar macrophages (AMs) help defend the lungs against infection, but during pneumonia many alveolar macrophages die. In this issue of the JCI, Malainou et al. explored the mechanism underpinning AM death during viral pneumonia and its effect on the outcomes of bacterial superinfection, a secondary infection that occurs before the first infection is cleared. In mouse models of influenza A infection, recruited neutrophils secreted TNF superfamily member 14 (TNFSF14), and AMs increased expression of the TNFSF14 receptors TNFSFR14 and type I transmembrane lymphotoxin β receptor (LTβR). TNFSF14 signaling via the LTβR was sufficient to cause AM apoptosis. TNFSF14 deficiency or blockade preserved AMs during influenza infection and diminished bacterial burdens and mouse mortality during pneumococcal superinfection. The adoptive transfer of AMs decreased the severity of pneumococcal superinfections, if those AMs lacked the LTβR. Thus, preserving AMs by interrupting TNFRSF14-LTβR interactions can make virus-infected lungs less susceptible to severe bacterial superinfection.

Authors

Elise M.R. Armstrong, Joseph P. Mizgerd

×

Figure 1

During influenza pneumonia, neutrophil-derived TNFSF14 uses the LTβR to trigger AM apoptosis, which increases susceptibility to severe bacterial superinfection.

Options: View larger image (or click on image) Download as PowerPoint
During influenza pneumonia, neutrophil-derived TNFSF14 uses the LTβR to ...
Studies by Malainou et. al. showed that neutrophils in the influenza-infected lung produced TNFSF14, whereas AMs increased expression of the TNFSF14 receptors TNFRSF14 and LTβR. TNFSF14 stimulated AM apoptosis primarily through the LTβR (8). These AM-depleted, influenza-infected lungs were susceptible to severe pneumococcal superinfection. However, deficiency of TNFSF14 during influenza infection (or its blockade prior to pneumococcal infection) made bacterial superinfection less severe. Although the adoptive transfer of WT or TNFRSF14-deficient AMs did not alter superinfection severity, the adoptive transfer of AMs lacking the LTβR (hence resistant to TNSF14-induced apoptosis) was sufficient to minimize the severity of superinfection. BMDM, bone marrow–derived macrophage.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts